Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy responseShengshan Xu, Zhuming Lu, Youbin Zheng et al.|BMC Cancer|2024Cited by 50
Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinomaShengshan Xu, Zhuming Lu, Haoxuan Ying et al.|BMC Cancer|2024Cited by 36
Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysisShengshan Xu, Zhuming Lu, Zhuowen Chen et al.|Frontiers in Immunology|2024Cited by 35
Causal links between immune cells and asthma: Insights from a Mendelian Randomization analysisShengshan Xu, Zhuming Lu, Tao Shen et al.|Journal of Asthma|2024Cited by 28